NasdaqGS:LFSTHealthcare
Stronger‑Than‑Expected Results, Guidance and Capital Moves Might Change The Case For Investing In LifeStance Health Group (LFST)
Recently, LifeStance Health Group reported quarterly revenue of US$403.5 million, a 21.2% year-on-year increase that surpassed analyst expectations, alongside revenue and EBITDA guidance that also came in ahead of forecasts.
At the same time, Goldman Sachs initiated coverage with a Neutral rating while the company completed a large secondary share offering with a planned 6 million share repurchase, underscoring both sector interest and active capital management.
Now we’ll examine how this...